Press Releases

Date Title and Summary
Toggle Summary Accuray Appoints Medtech Veteran Suzanne Winter as Chief Commercial Officer
SUNNYVALE, Calif. , Oct. 21, 2019 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY) announced today that Suzanne Winter has joined the company as Senior Vice President, Chief Commercial Officer effective October 21, 2019 . Ms. Winter will have global responsibility for the commercial function
Toggle Summary Accuray To Report Fiscal 2020 First Quarter Financial Results on October 29, 2019
  SUNNYVALE, Calif. , Oct. 10, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its first quarter ended September 30, 2019 on Tuesday, October 29, 2019 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
Toggle Summary Accuray Educates Radiation Oncology Practices on the Potential Impact of the Proposed Alternative Payment Model (RO-APM)
SUNNYVALE, Calif. , Sept. 19, 2019 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) today published an informational guide designed to help radiation oncology practices understand the complexities of the much-anticipated proposed Medicare & Medicaid reimbursement changes.
Toggle Summary Data Published in The Lancet Oncology Suggest CyberKnife® Prostate Patients Experienced Lower Levels of Acute Genitourinary Toxicity (Grade 2 or Higher) Than Patients Treated on a Conventional Linear Accelerator
SUNNYVALE, Calif. , Sept. 17, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announces that The Lancet Oncology , a high impact and leading global peer-reviewed oncology journal, has published patient- and clinician-reported outcomes data from the PACE — Prostate Advances in Comparative
Toggle Summary China Announces Tariff Exclusion for Medical Linear Accelerators
SUNNYVALE, Calif. , Sept. 16, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced that, on September 11, 2019 , China's Customs Tariff Commission of the State Council issued a tariff exemption for medical linear accelerators.  The tariff exemption, which will be effective September
Toggle Summary Accuray Appoints Healthcare Veteran James M. Hindman to Board of Directors
SUNNYVALE, Calif. , Sept. 12, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) strengthened its Board of Directors with the appointment of James (Jim) M. Hindman , effective as of September 6, 2019 , and expanding the company's Board to nine members. Mr.
Toggle Summary Geisinger Medical Center is First in Pennsylvania to Treat Cancer Patients with Accuray Radixact® System
Leading Health Services Organization Hospital Selected the New Radiation Therapy Device to Expand Its Clinical Capabilities and Provide Treatment Options for a Wider Range of Patients SUNNYVALE, Calif. , Sept. 10, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the
Toggle Summary Accuray to Set ASTRO 2019 in Motion with Patient-first Cancer Treatment Innovations
SUNNYVALE, Calif. , Sept. 5, 2019 /PRNewswire/ -- Accuray Incorporated  (NASDAQ: ARAY) announced today that it will showcase its industry-leading motion-synchronization cancer treatment technologies at the upcoming American Society for Radiation Oncology (ASTRO) Annual Meeting taking place
Toggle Summary Accuray to Host ASTRO Investor Meeting on September 16, 2019
Presentations will be Live Webcast and Commence at 3:00pm CT SUNNYVALE, Calif. , Sept. 4, 2019 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) announced today that the Company will host an Investor Meeting during the American Society of Radiation Oncology (ASTRO) Annual Meeting, being held
Toggle Summary Froedtert & the Medical College of Wisconsin Cancer Network is First in the World to Treat Cancer Patient Using the Accuray Radixact® System with Synchrony® Motion Tracking and Correction Technology
Advanced Radiation Therapy Delivery System and Intrafraction Motion Synchronization Functionality Enable Precise, Efficient Treatment of a 45-Year-Old Man with Lung Cancer SUNNYVALE, Calif. , Aug. 21, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that physicians at the